483 related articles for article (PubMed ID: 25331948)
1. The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.
Paris D; Ait-Ghezala G; Bachmeier C; Laco G; Beaulieu-Abdelahad D; Lin Y; Jin C; Crawford F; Mullan M
J Biol Chem; 2014 Dec; 289(49):33927-44. PubMed ID: 25331948
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
[TBL] [Abstract][Full Text] [Related]
4. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
6. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.
Lloret A; Badia MC; Giraldo E; Ermak G; Alonso MD; Pallardó FV; Davies KJ; Viña J
J Alzheimers Dis; 2011; 27(4):701-9. PubMed ID: 21876249
[TBL] [Abstract][Full Text] [Related]
8. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
9. Nilvadipine suppresses inflammation via inhibition of P-SYK and restores spatial memory deficits in a mouse model of repetitive mild TBI.
Morin A; Mouzon B; Ferguson S; Paris D; Browning M; Stewart W; Mullan M; Crawford F
Acta Neuropathol Commun; 2020 Oct; 8(1):166. PubMed ID: 33076989
[TBL] [Abstract][Full Text] [Related]
10. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
Huang HC; Tang D; Xu K; Jiang ZF
J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406
[TBL] [Abstract][Full Text] [Related]
12. Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.
Paris D; Bachmeier C; Patel N; Quadros A; Volmar CH; Laporte V; Ganey J; Beaulieu-Abdelahad D; Ait-Ghezala G; Crawford F; Mullan MJ
Mol Med; 2011; 17(3-4):149-62. PubMed ID: 21170472
[TBL] [Abstract][Full Text] [Related]
13. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
[TBL] [Abstract][Full Text] [Related]
14. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
15. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
16. Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation
Schweig JE; Yao H; Coppola K; Jin C; Crawford F; Mullan M; Paris D
J Biol Chem; 2019 Sep; 294(36):13378-13395. PubMed ID: 31324720
[TBL] [Abstract][Full Text] [Related]
17. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
[TBL] [Abstract][Full Text] [Related]
18. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
19. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
